Search research articles
Contact Us
Filters
Showing results (31-40 of 1,304) with videos related to
Page
of 131
Sort By:
Expert Review of Neurotherapeutics
|
September 2, 2008
Olanzapine/fluoxetine combination for treatment-resistant depression: efficacy and clinical utility
Seetal Dodd, Michael Berk
Molecular Neurobiology
|
December 1, 2016
Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia
Monojit Debnath, Michael Berk
The Lancet. Psychiatry
|
February 11, 2017
Cognition in psychiatric disorders: from models to management
Michael Berk, Lesley Berk
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
February 20, 2004
Mood stabilizers and treatment adherence in bipolar disorder: addressing adverse events
Michael Berk, Lesley Berk
JAMA
|
November 7, 2018
Medications With Depression as an Adverse Effect
Bruno Agustini, Michael Berk
Evidence-Based Mental Health
|
July 27, 2004
Review: rapid cycling bipolar disorder associated with female gender and bipolar type II subgroup
Michael Berk, Seetal Dodd
Human Psychopharmacology
|
December 23, 2004
Antidepressants and adolescents: the bipolar confound?
Michael Berk, Seetal Dodd
Evidence-Based Mental Health
|
January 27, 2007
Higher dose venlafaxine may improve response compared with standard doses in people with major depressive disorder and intolerance or non-responsiveness to SSRIs
Seetal Dodd, Michael Berk
The Australian and New Zealand Journal of Psychiatry
|
September 28, 2013
Contextualising the biology of psychiatry within its social environment
Michael Berk, Ajeet Singh
Asian Journal of Psychiatry
|
December 16, 2014
Evolution of adolescent mental health in a rapidly changing socioeconomic environment: a review of mental health studies in adolescents in India over last 10 years
Shilpa Aggarwal, Michael Berk
Page
of 131
Search research articles
Search
Showing results (31-40 of 1,304) with videos related to
Sort By:
Page
of 131
Expert Review of Neurotherapeutics
|
September 2, 2008
Olanzapine/fluoxetine combination for treatment-resistant depression: efficacy and clinical utility
Seetal Dodd, Michael Berk
Molecular Neurobiology
|
December 1, 2016
Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia
Monojit Debnath, Michael Berk
The Lancet. Psychiatry
|
February 11, 2017
Cognition in psychiatric disorders: from models to management
Michael Berk, Lesley Berk
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
February 20, 2004
Mood stabilizers and treatment adherence in bipolar disorder: addressing adverse events
Michael Berk, Lesley Berk
JAMA
|
November 7, 2018
Medications With Depression as an Adverse Effect
Bruno Agustini, Michael Berk
Evidence-Based Mental Health
|
July 27, 2004
Review: rapid cycling bipolar disorder associated with female gender and bipolar type II subgroup
Michael Berk, Seetal Dodd
Human Psychopharmacology
|
December 23, 2004
Antidepressants and adolescents: the bipolar confound?
Michael Berk, Seetal Dodd
Evidence-Based Mental Health
|
January 27, 2007
Higher dose venlafaxine may improve response compared with standard doses in people with major depressive disorder and intolerance or non-responsiveness to SSRIs
Seetal Dodd, Michael Berk
The Australian and New Zealand Journal of Psychiatry
|
September 28, 2013
Contextualising the biology of psychiatry within its social environment
Michael Berk, Ajeet Singh
Asian Journal of Psychiatry
|
December 16, 2014
Evolution of adolescent mental health in a rapidly changing socioeconomic environment: a review of mental health studies in adolescents in India over last 10 years
Shilpa Aggarwal, Michael Berk
Page
of 131